Initial Statement of Beneficial Ownership (3)
11 Août 2015 - 11:56PM
Edgar (US Regulatory)
FORM 3
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0104
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Luthin James C
|
2. Date of Event Requiring Statement (MM/DD/YYYY)
8/9/2015
|
3. Issuer Name
and
Ticker or Trading Symbol
BioScrip, Inc. [BIOS]
|
(Last)
(First)
(Middle)
C/O BIOSCRIP INC., 10050 CROSSTOWN CIRCLE #300
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___
X
___ Officer (give title below)
_____ Other (specify below)
SVP & Chief Operating Officer /
|
(Street)
EDEN PRAIRIE, MN 55344
(City)
(State)
(Zip)
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Beneficially Owned
|
1.Title of Security
(Instr. 4)
|
2. Amount of Securities Beneficially Owned
(Instr. 4)
|
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
|
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 4)
|
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
|
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
|
4. Conversion or Exercise Price of Derivative Security
|
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
|
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Employee Stock Option (Right to Buy)
|
6/1/2016
(1)
|
6/1/2025
|
Common Stock, $.0001 Par Value
|
150000
|
$3.43
|
D
|
|
Explanation of Responses:
|
(
1)
|
Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.
|
Remarks:
Exhibit 24.1 Power of Attorney
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Luthin James C
C/O BIOSCRIP INC.
10050 CROSSTOWN CIRCLE #300
EDEN PRAIRIE, MN 55344
|
|
|
SVP & Chief Operating Officer
|
|
Signatures
|
/s/ Caroline Fox, attorney-in-fact for Mr. Luthin
|
|
8/11/2015
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 5(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Juil 2024 à Août 2024
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Août 2023 à Août 2024